Articles On Polynovo (ASX:PNV)

It was a day for the record books for the S&P/ASX 200 Index (ASX: XJO) this Thursday, with the index once again resetting its all-time record high. The ASX 200 ended up losing most of its earl...

ASX healthcare leaders are often involved in multiple companies or organisations  Syntara CEO Gary Philips believes seasoned executives can help develop the sector in Australia Dimerix CEO and MD Dr Nina Webster has two other key positions...

ASX health stocks up 0.6% over past week, while the broader market rises 1%  EBR Systems is up ~58% in a month, briefly hitting Morgans price target of $1.76 Morgans drops rating of Nanosonics to a hold despite strong H1 FY25 Healthcare a...

Pic via Getty ImagesRadiopharmaceuticals company Telix reports sustained revenue growth in Q4 FY24 ASX health stocks fall about 2.8% over past week Neuren’s partner Acadia submits marketing authorisation application in Europe for trofine...

If you are looking for some exposure to the healthcare sector, then it could be worth looking at the two ASX 200 healthcare shares in this article. They have been named as top buys by analysts at Bell Potter in 2025. Here's what the broker...

It was a day of relief and optimism for the S&P/ASX 200 Index (ASX: XJO)  and ASX investors this Tuesday. After several days of sometimes nasty drops, investors turned the ship around today....

If you are looking for exposure to the small side of town, then it could be worth checking out the small cap ASX share in this article. That's because analysts at Bell Potter are tipping it as a top buy in 2025. Let's see what the broker is...

Mixed signals for ASX, so choose wisely says Morningstar Telcos and energy strong, but some sectors are overpriced Retail and healthcare under pressure, but there’s promise   The ASX is full of mixed signals right now, with some sectors l...

AVITA Medical Inc (ASX: AVH) shares are having a tough time on Wednesday. In morning trade, the ASX All Ords stock is down 17% to $3.62. Why is this ASX All Ords stock down 17%? This commercial-stage regenerative medicine company's shares a...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

In early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to finish the year with another decline. At the time of writing, the benchmark index is down 0.7% to 8,174.7 points. Four ASX shares that are not letting that hol...

Pro Medicus Limited (ASX: PME) shares are rising on Monday morning. At the time of writing, the ASX 200 tech stock is up 1% to $258.00. This has been driven by the release of another positive announcement. ASX 200 tech stock rises on contra...

The team at Goldman Sachs has been busy running the rule over some ASX 200 shares recently. Two that have received big thumbs up are listed below. Here's why they broker thinks they are buys: Codan Ltd (ASX: CDA) Goldman is a fan of this m...

The S&P/ASX 200 Index (ASX: XJO) is on form again after returning from the Christmas break. At the time of writing, the benchmark index is up 0.4% to 8,255.7 points. Four ASX shares that are rising more than most today are listed below...

Do you have $1,000 to invest in ASX 200 stocks? If you do, then the stocks in this article could be great destinations for these funds according to analysts. Here's what you need to know about them: Endeavour Group Ltd (ASX: EDV) This fir...

I hope everyone who celebrates today is having a wonderful, festive start to their day. Did you receive a pair of socks today? What about a pair of stocks? Receiving S&P/ASX 200 Index (ASX: XJO) shares as a gift is probably not the most...

The S&P/ASX 200 Index (ASX: XJO) is having a volatile session but is currently on course to record a small gain. In early afternoon trade, the benchmark index is up slightly to 8,208.5 points. Four ASX shares that are rising more than m...

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading...

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week with its best session in six months. The benchmark index rose 1.7% to 8,201.6 points. Will the market be able to build on this during Tuesday's shortened session? Here are f...

The S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a gain. At the time of writing, the benchmark index is up 0.75% to 8,126.4 points. Four ASX shares that are rising more than most today are listed below. Here's why t...

The Telstra Group Ltd (ASX: TLS) share price is pushing higher on Monday morning. At the time of writing, the telco giant's shares are up 0.5% to $4.00. This follows the release of a big announcement relating to the company's stake in the F...

Pro Medicus Limited (ASX: PME) shares are starting the week on a positive note. In morning trade, the health imaging technology company's shares are up 1.5% to $251.90. What's happening? Investors have been buying the high-flying ASX tech s...

Bell Potter bullish on these tech and healthcare stocks Life360, Light & Wonder, and Gentrack in tech And PolyNovo and CSL among Bell Potter’s healthcare picks   As we look towards 2025, Australian stockbroking and financial advisory...

From artificial intelligence (A.I) to zygotes, the biotech sector this year delivered the A to Z of excitement, intrigue, occasional disappointment and downright disaster. His virtual stethoscope on hand, Dr Boreham was on duty to diagnose...

Wanting some exposure to the healthcare sector in 2025? If you are, then it could be worth looking at the ASX 200 healthcare stocks that Bell Potter has named as its top picks for the year ahead. They are as follows: Clarity Pharmaceutical...

Last week I looked at a couple of ASX 200 shares that Bell Potter has named as best buys for 2025. You can read about the first two here. Now let's take a look at a couple more that have made its list for the year ahead. They are as follows...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

Highlights GR Engineering Services GNG shows impressive earnings growth, with a debt-free balance sheet. Polynovo PNV presents a compelling opportunity in wound care, despite recent price fluctuations. Aroa Biosurgery ARX delivers str...

It ended up being a happy hump day indeed for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Wednesday. After a rough session yesterday, ASX 200 investors were back to their happy p...

It was a bullish start to the trading week for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Monday, with the markets hitting another new all-time record high. After ending last w...

Robert F Kennedy Junior’s appointment as US health czar means an unpredictable time for ASX healthcare companies operating in the US The likely consequences are not all bad, with many stocks poised to benefit from tax cuts and a more effic...

ASX health stocks fall 1.3% in past five days, while broader market is marginally up 0.7%  Neuren soars on sale of priority review voucher and $50 million share buyback Neurizon releases positive preclinical results on lead drug candidate...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are indicating a rather lacklustre start to the final week for October i...

Highlights ASX market sees fluctuation amid Wall Street’s mixed performance 4DS Memory, Image Resources, and PolyNovo show varying financial strengths Highlighted companies stand out in semiconductor, mining, and medical device sector...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

  Singapore’s medical regulator this week approved Orthocell’s leading nerve-repair device Remplir Remplir shows great promise in restoring function for paraplegics and quadriplegics Orthocell estimates the potential global market at US$33...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

There are a lot of options for investors to choose from on the Australian share market. So, let's take a look at three ASX shares from different sides of the market that analysts are tipping as buys. They are as follows: Polynovo Ltd (ASX:...

The S&P/ASX 200 Index (ASX: XJO) continues its upward momentum, recently hitting an all-time high of 8,246.2 points before closing at 8,215.8, marking a 0.29% gain. This surge follows global market trends, with investor confidence high...

The S&P/ASX 200 Index (ASX: XJO) hit another all-time record on Friday, stretching to 8,246.2 points before settling back to 8,215.8 points, up 0.29% at the time of writing. Seven ASX 200 directors have sold significant portions of t...

It's been a fairly miserable Thursday session for ASX shares so far today. At the time of writing, the S&P/ASX 200 Index (ASX: XJO) has slipped by 0.04% and is back under 8,140 points. But let's talk about what's going on with the ResMe...

It ended up being quite a wonderful day for the S&P/ASX 200 Index (ASX: XJO) this Tuesday. The ASX 200 managed to add 0.24% to its value and closed up at 8...

No company wants sub-optimal returns on their product – and pain-management house Medical Developments International (ASX:MVP) is no exception. For some years, management has believed that customers undervalued the worth of its flagship pro...

The team at Morgans has been busy picking out its best ASX share ideas for September. These are the stocks that it thinks offer the highest risk-adjusted returns over a 12-month timeframe supported by a higher-than-average level of confid...

The Australian sharemarket showed positive movement in early afternoon trading on Tuesday, recovering from last week’s downturn. The benchmark S&P/ASX 200 Index rose by 0.6%, or 43.9 points, to reach 8,032, driven higher by gains in the...

Australian shares showed a notable rebound at the start of trading on Tuesday, tracking a rally from Wall Street and recovering from last week’s sell-off. The benchmark S&P/ASX 200 Index climbed 0.6% or 44.4 points to reach 8,032.5, dri...

Australian shares rebounded on Tuesday, reflecting a rally on Wall Street as investors cautiously re-entered the market following last week’s sell-off. At 11:30am, the S&P/ASX 200 is 0.86 per cent higher at 8,057.10, driven by gains in...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

After snatching a small win from the jaws of defeat yesterday, the S&P/ASX 200 Index (ASX: XJO) wasn't so lucky this Tuesday. After a bouncy session, the ASX 200 c...